Beyond Air Inc. Common Stock (XAIR)

FairStock Score: 63/100 — STEADY

Key Financials

Strengths

• Revenue growth of 104.7% demonstrates strong top-line momentum

Concerns

• High leverage at 2.85x debt-to-equity increases financial risk and interest expense burden
• Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
• Altman Z-Score of -11.5 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

Beyond Air Inc. Common Stock is a micro-cap healthcare company valued at $5 million. Revenue stands at $7 million, though the company is currently unprofitable. From a quality standpoint, Beyond shows distressed Altman Z-Score of -11.5 warrants caution and negative ROE indicating losses. Growth dynamics show revenue growing at 104.7% and profit growth of 43.7%. Our composite FairStock Score of 63/100 reflects above-average fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.

Bull Case

Beyond's 105% revenue growth trajectory could accelerate as it captures additional market share in the healthcare sector. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer